FMA
ANAC

FNY Managed Accounts’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

FNY Managed Accounts’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,000
Closed -$57.9K – 692
2015
Q1 		$57.9K Buy
+1,000
New +$42.5K 0.05% 129

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

FNY Managed Accounts's ANAC Position: Q2 2015 in Review

FNY Managed Accounts sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2015, closing a stake of 1,000 shares — an estimated $57.9K sold.

FNY Managed Accounts first reported a position in ANAC in Q1 2015 and held it in 1 quarter. The position peaked at $57.9K in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

  • FNY Managed Accounts reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
  • FNY Managed Accounts sold 1,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $57.9K.
  • FNY Managed Accounts first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 1 quarter.
  • FNY Managed Accounts's ANACOR PHARMACEUTICALS INC COM position peaked at $57.9K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on FNY Managed Accounts's 13F filing for Q2 2015, filed 30 Jul 2015.